关注
Emily G. Hamilton
Emily G. Hamilton
Postdoctoral Scholar, Stanford University
在 stanford.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
MR Corces, AE Trevino, EG Hamilton, PG Greenside, ...
Nature methods 14 (10), 959-962, 2017
18622017
Integrating genomic features for non-invasive early lung cancer detection
JJ Chabon, EG Hamilton, DM Kurtz, MS Esfahani, EJ Moding, H Stehr, ...
Nature 580 (7802), 245-251, 2020
4762020
DNA methylation and somatic mutations converge on the cell cycle and define similar evolutionary histories in brain tumors
T Mazor, A Pankov, BE Johnson, C Hong, EG Hamilton, RJA Bell, ...
Cancer cell 28 (3), 307-317, 2015
2642015
Noninvasive early identification of therapeutic benefit from immune checkpoint inhibition
BY Nabet, MS Esfahani, EJ Moding, EG Hamilton, JJ Chabon, H Rizvi, ...
Cell 183 (2), 363-376. e13, 2020
2592020
Convergence of placenta biology and genetic risk for schizophrenia
G Ursini, G Punzi, Q Chen, S Marenco, JF Robinson, A Porcelli, ...
Nature medicine 24 (6), 792-801, 2018
2502018
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
DM Kurtz, J Soo, L Co Ting Keh, S Alig, JJ Chabon, BJ Sworder, A Schultz, ...
Nature biotechnology 39 (12), 1537-1547, 2021
1922021
Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer
TD Azad, AA Chaudhuri, P Fang, Y Qiao, MS Esfahani, JJ Chabon, ...
Gastroenterology 158 (3), 494-505. e6, 2020
1742020
KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition
MS Binkley, YJ Jeon, M Nesselbush, EJ Moding, BY Nabet, D Almanza, ...
Cancer discovery 10 (12), 1826-1841, 2020
1052020
Inferring gene expression from cell-free DNA fragmentation profiles
MS Esfahani, EG Hamilton, M Mehrmohamadi, BY Nabet, SK Alig, ...
Nature biotechnology 40 (4), 585-597, 2022
912022
Polybrominated diphenyl ethers (PBDEs) and hydroxylated PBDE metabolites (OH-PBDEs) in maternal and fetal tissues, and associations with fetal cytochrome P450 gene expression
AR Zota, SD Mitro, JF Robinson, EG Hamilton, JS Park, E Parry, ...
Environment international 112, 269-278, 2018
742018
Human placental cytotrophoblast epigenome dynamics over gestation and alterations in placental disease
B Zhang, MY Kim, GN Elliot, Y Zhou, G Zhao, D Li, RF Lowdon, ...
Developmental cell 56 (9), 1238-1252. e5, 2021
362021
Genomic profiling of BDE-47 effects on human placental cytotrophoblasts
JF Robinson, M Kapidzic, EG Hamilton, H Chen, KW Puckett, Y Zhou, ...
Toxicological Sciences 167 (1), 211-226, 2019
352019
Differences in cytochrome p450 enzyme expression and activity in fetal and adult tissues
JF Robinson, EG Hamilton, J Lam, H Chen, TJ Woodruff
Placenta 100, 35-44, 2020
272020
Transcriptional dynamics of cultured human villous cytotrophoblasts
JF Robinson, M Kapidzic, M Gormley, K Ona, T Dent, H Seifikar, ...
Endocrinology 158 (6), 1581-1594, 2017
262017
A comprehensive circulating tumor DNA assay for detection of translocation and copy-number changes in pediatric sarcomas
AT Shah, TD Azad, MR Breese, JJ Chabon, EG Hamilton, K Straessler, ...
Molecular cancer therapeutics 20 (10), 2016-2025, 2021
192021
Placental gene expression mediates the interaction between obstetrical history and genetic risk for schizophrenia
G Ursini, G Punzi, Q Chen, S Marenco, JF Robinson, A Porcelli, ...
bioRxiv, 147207, 2017
92017
Phased variant enrichment for enhanced minimal residual disease detection from cell-free DNA
DM Kurtz, J Soo, S Alig, LCT Keh, C Macaulay, MC Jin, F Scherer, ...
Blood 134, 552, 2019
62019
Distinct chromatin accessibility profiles of lymphoma subtypes revealed by targeted cell free dna profiling
M Mehrmohamadi, MS Esfahani, J Soo, F Scherer, JG Schroers-Martin, ...
Blood 132, 672, 2018
52018
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
A Passaro, M Al Bakir, EG Hamilton, M Diehn, F André, S Roy-Chowdhuri, ...
Cell 187 (7), 1617-1635, 2024
42024
Leveraging phased variants for personalized minimal residual disease detection in localized non-small cell lung cancer.
DM Kurtz, JJ Chabon, B Sworder, L Co Ting Keh, J Soo, S Alig, A Schultz, ...
Journal of Clinical Oncology 39 (15_suppl), 8518-8518, 2021
32021
系统目前无法执行此操作,请稍后再试。
文章 1–20